Under construction – not a live service
Sign in
Taking people in FranceNo phase

Measuring Thigh Muscle Size and Stiffness in People With COPD

Checks thigh muscle size and stiffness in adults with COPD, before and after rehabilitation.

Plain-language title generated from the registry record
Registry title: Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD

Key facts

Where
Le Havre, FranceSee the site

Where in France

  • Groupe Hospitalier du HavreLe Havre, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Groupe Hospitalier du Havre
Trial code
NCT06994689
Record updated
21 January 2026
Original description
A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association between a loss of quadriceps muscle mass and premature death.Read full original descriptionShow less

Clinimetric Properties Assessment of Quadriceps Muscle Mass and Stiffness Using Perimetry and ShearWave Elastography in Patients With COPD : a Prospective Observational Study

A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association between a loss of quadriceps muscle mass and premature death.

This study aims to investigate the clinimetric properties of a simple quadriceps perimetry and ShearWave elastography to improve the monitoring of skeletal muscle function in patients with COPD.

Inclusion: COPD patients; Adults (>18 years old); Patients starting a pulmonary rehabilitation (PR) programme.

Exclusion: Patients with lower limb amputation or history of neuromuscular disease; Patients included in other research protocol; Minors or under guardianship; Pregnancy; Cardiovascular contradications for PR.

ClinicalTrials.gov NCT06994689